UNITED THERAPEUTICS CORP (UTHR) Stock Analyst Ratings
NASDAQ:UTHR • US91307C1027
499.957 USD
-13.86 (-2.7%)
Last: Mar 3, 2026, 02:21 PM
ChartMill assigns a Buy % Consensus number of 82% to UTHR. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 546.81. This target is 9.37% above the current price.
- UTHR was analyzed by 21 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about UTHR.
- In the previous month the buy percentage consensus was at a similar level.
- UTHR was analyzed by 21 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-02-26 | TD Cowen | Maintains | Buy -> Buy |
| 2026-02-26 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2026-02-26 | RBC Capital | Maintains | Outperform -> Outperform |
| 2026-02-26 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2026-02-26 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2026-01-06 | UBS | Maintains | Buy -> Buy |
| 2025-11-06 | UBS | Maintains | Buy -> Buy |
| 2025-10-30 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-10-30 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-10-30 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-10-10 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-09-29 | UBS | Maintains | Buy -> Buy |
| 2025-09-26 | RBC Capital | Initiate | Outperform |
| 2025-09-10 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2025-09-05 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-09-05 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-09-04 | UBS | Maintains | Buy -> Buy |
| 2025-09-03 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-09-02 | B of A Securities | Maintains | Neutral -> Neutral |
| 2025-09-02 | Jefferies | Maintains | Buy -> Buy |
| 2025-08-13 | UBS | Maintains | Buy -> Buy |
| 2025-07-31 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-07-31 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-07-10 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-07-08 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-06-30 | UBS | Maintains | Buy -> Buy |
| 2025-06-11 | B of A Securities | Maintains | Neutral -> Neutral |
| 2025-06-02 | Cantor Fitzgerald | Initiate | Overweight |
| 2025-05-05 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-05-01 | JP Morgan | Maintains | Overweight -> Overweight |
UNITED THERAPEUTICS CORP / UTHR FAQ
What is the price target for UTHR stock?
21 analysts have analysed UTHR and the average price target is 546.8 USD. This implies a price increase of 9.37% is expected in the next year compared to the current price of 499.957.
What is the consensus rating for UNITED THERAPEUTICS CORP (UTHR) stock?
The consensus rating for UNITED THERAPEUTICS CORP (UTHR) is 81.9048 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for UTHR stock?
The number of analysts covering UNITED THERAPEUTICS CORP (UTHR) is 21.